Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 43 Rectal Neoplasms 12 Colonic Neoplasms 12 Neoplasm Metastasis 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Gallbladder Neoplasms 3 Colorectal Cancer Metastatic 3 Cholangiocarcinoma 3 Neutropenia 2 Neoplasms 2 Bile Duct Neoplasms 2 Adenocarcinoma 2 mCRC 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Recurrence 1 Pretreated Metastatic Colorectal Cancer 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Nasopharyngeal Carcinoma 1 Microsatellite-stable Colorectal Cancer 1 Metastatic Gastric Adenocarcinoma 1 High-grade Extra Pulmonary Neuroendocrine Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Gastric and Gastroesophageal Junction Adenocarcinoma 1 Gastric Cancer Adenocarcinoma Metastatic 1 Gastric Adenocarcinoma 1

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 3 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cisplatin 3 Capecitabine 3 vistusertib 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Technetium 2 Specimen Handling 2 Sirolimus 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × trifluridine tipiracil drug combination × Clear all

NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡